Literature DB >> 15322781

Atypical teratoid/rhabdoid tumor: an unusual presentation.

Chirag D Gandhi1, Mark D Krieger, J Gordon McComb.   

Abstract

Atypical teratoid/ rhabdoid tumor (AT/RT) of the central nervous system is a rare, highly aggressive malignancy of infancy. Although it is reported infrequently in the literature, it has often been histologically confused with a primitive neuroectodermal tumor (PNET)/medulloblastoma (MB) but has a much worse prognosis. We present an infant with two AT/RT tumors, one suprasellar in location and the other within the vermis without evidence of tumor elsewhere. What makes this case unusual is that there were two separate lesions in different cranial compartments, with no evidence of subarachnoid seeding. In addition, the lesions had different magnetic resonance imaging (MRI) characteristics even though they were histologically the same.

Entities:  

Mesh:

Year:  2004        PMID: 15322781     DOI: 10.1007/s00234-004-1251-x

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  4 in total

1.  Atypical teratoid/rhabdoid tumor of the central nervous system: a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: a Pediatric Oncology Group study.

Authors:  P C Burger; I T Yu; T Tihan; H S Friedman; D R Strother; J L Kepner; P K Duffner; L E Kun; E J Perlman
Journal:  Am J Surg Pathol       Date:  1998-09       Impact factor: 6.394

2.  Epidemiology of central nervous system tumors in childhood and adolescence based on the new WHO classification.

Authors:  C H Rickert; W Paulus
Journal:  Childs Nerv Syst       Date:  2001-09       Impact factor: 1.475

Review 3.  Central nervous system atypical teratoid tumor/rhabdoid tumor: response to intensive therapy and review of the literature.

Authors:  J M Hilden; J Watterson; D C Longee; C L Moertel; M E Dunn; J Kurtzberg; B W Scheithauer
Journal:  J Neurooncol       Date:  1998-12       Impact factor: 4.130

4.  Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity.

Authors:  L B Rorke; R J Packer; J A Biegel
Journal:  J Neurosurg       Date:  1996-07       Impact factor: 5.115

  4 in total
  6 in total

1.  Primary intracranial atypical teratoid/rhabdoid tumors of infancy and childhood: MRI features and patient outcomes.

Authors:  S P Meyers; Z P Khademian; J A Biegel; S H Chuang; D N Korones; R A Zimmerman
Journal:  AJNR Am J Neuroradiol       Date:  2006-05       Impact factor: 3.825

2.  How specific is the MRI appearance of supratentorial atypical teratoid rhabdoid tumors?

Authors:  Kong Jung Au Yong; Jacob L Jaremko; Lennart Jans; Ravi Bhargava; Lee T Coleman; Vivek Mehta; Michael R Ditchfield
Journal:  Pediatr Radiol       Date:  2012-11-10

3.  Atypical teratoid rhabdoid tumor in the first year of life: the Canadian ATRT registry experience and review of the literature.

Authors:  Mary Fossey; Haocheng Li; Samina Afzal; Anne-Sophie Carret; David D Eisenstat; Adam Fleming; Juliette Hukin; Cynthia Hawkins; Nada Jabado; Donna Johnston; Tania Brown; Valerie Larouche; Katrin Scheinemann; Douglas Strother; Beverly Wilson; Shayna Zelcer; Annie Huang; Eric Bouffet; Lucie Lafay-Cousin
Journal:  J Neurooncol       Date:  2017-01-19       Impact factor: 4.130

Review 4.  Atypical teratoid/rhabdoid tumor: the controversy behind radiation therapy.

Authors:  Sarah E Squire; Michael D Chan; Karen J Marcus
Journal:  J Neurooncol       Date:  2006-07-20       Impact factor: 4.130

5.  CT and MR imaging in atypical teratoid/rhabdoid tumors of the central nervous system.

Authors:  Monika Warmuth-Metz; Brigitte Bison; Elke Dannemann-Stern; Rolf Kortmann; Stefan Rutkowski; Torsten Pietsch
Journal:  Neuroradiology       Date:  2008-05       Impact factor: 2.804

6.  Magnetic resonance imaging surrogates of molecular subgroups in atypical teratoid/rhabdoid tumor.

Authors:  Johannes Nowak; Karolina Nemes; Annika Hohm; Lindsey A Vandergrift; Martin Hasselblatt; Pascal D Johann; Marcel Kool; Michael C Frühwald; Monika Warmuth-Metz
Journal:  Neuro Oncol       Date:  2018-11-12       Impact factor: 12.300

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.